Utilization of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana for Total Hip Replacement at a Tertiary Care Center in North India: A Retrospective Analysis.
- 1Department of Orthopedic Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract
To characterize the pattern of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) utilization for total hip replacement (THR) at a tertiary care center in North India, including its effect on patient demographics, diagnostic profile, and implant selection, given that THR in India is driven predominantly by avascular necrosis (AVN) of the femoral head and fracture sequelae rather than osteoarthritis, and that PM-JAY's institution-level effect on THR utilization and implant selection has not been well described. This retrospective single-center study reviewed all THR procedures performed at a tertiary orthopedic center in North India from January 2024 to December 2025, extracting demographic, diagnostic, procedural, implant, and financing data from operative registers and comparing years using chi-square and independent-samples t-tests. Among 188 THR procedures (75 in 2024, 113 in 2025; a 50.7% rise), mean age was 45.6 ± 14.4 years and 67.0% of patients were male. AVN of the femoral head was the leading indication (44.1%). PM-JAY financed 138 procedures (73.4%), self-payment 41 (21.8%), the state-level Himcare scheme 6 (3.2%), and non-governmental organization-supported care 3 (1.6%); PM-JAY alone funded 88.9% of revision THRs. Domestic implants predominated in PM-JAY (78.3%) and Himcare (83.3%) cases versus 36.6% of self-financed cases, despite hip implants not being subject to government price capping. PM-JAY, with Himcare, is the predominant financing mechanism for THR at this center, funding over three-quarters of procedures and most revision surgery in a young, male-predominant population, supporting an expanding role for public insurance in financing major arthroplasty in India.
Related
- Role of awareness, support systems, and sociodemographic factors in determining utilization of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana among beneficiaries in Gujarat, India
- Awareness, Perception, Utilization, and Challenges of Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana Among Peri-Urban Residents of Kanpur, Uttar Pradesh: A Community-Based Cross-Sectional Study
- Knowledge, enrollment, and utilization of the Ayushman Bharat Vay Vandana scheme among the elderly individuals reporting to a tertiary care hospital
- GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Healthcare Utilization in Bipolar Disorder with Chronic Kidney Disease
- Effect of intraoperative tranexamic acid use on postoperative bleeding in tumor replacement surgery : A retrospective cohort study
BibTeX
@article{raj2026utilization,
title = {{Utilization of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana for Total Hip Replacement at a Tertiary Care Center in North India: A Retrospective Analysis.}},
author = {Sharath Raj and Deepak Kumar and Pronay Biswas and Souvik Das and Aditya Shah and Vijay G Goni},
journal = {Journal of orthopaedic case reports},
year = {2026},
month = nov,
doi = {10.13107/jocr.2026.v16.i11.8512},
url = {https://europepmc.org/article/MED/42997224},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Utilization of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana for Total Hip Replacement at a Tertiary Care Center in North India: A Retrospective Analysis.
AU - Sharath Raj
AU - Deepak Kumar
AU - Pronay Biswas
AU - Souvik Das
AU - Aditya Shah
AU - Vijay G Goni
PY - 2026
DA - 2026/11/01
JO - Journal of orthopaedic case reports
DO - 10.13107/jocr.2026.v16.i11.8512
UR - https://europepmc.org/article/MED/42997224
AB - To characterize the pattern of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) utilization for total hip replacement (THR) at a tertiary care center in North India, including its effect on patient demographics, diagnostic profile, and implant selection, given that THR in India is driven predominantly by avascular necrosis (AVN) of the femoral head and fracture sequelae rather than osteoarthritis, and that PM-JAY's institution-level effect on THR utilization and implant selection has not been well described. This retrospective single-center study reviewed all THR procedures performed at a tertiary orthopedic center in North India from January 2024 to December 2025, extracting demographic, diagnostic, procedural, implant, and financing data from operative registers and comparing years using chi-square and independent-samples t-tests. Among 188 THR procedures (75 in 2024, 113 in 2025; a 50.7% rise), mean age was 45.6 ± 14.4 years and 67.0% of patients were male. AVN of the femoral head was the leading indication (44.1%). PM-JAY financed 138 procedures (73.4%), self-payment 41 (21.8%), the state-level Himcare scheme 6 (3.2%), and non-governmental organization-supported care 3 (1.6%); PM-JAY alone funded 88.9% of revision THRs. Domestic implants predominated in PM-JAY (78.3%) and Himcare (83.3%) cases versus 36.6% of self-financed cases, despite hip implants not being subject to government price capping. PM-JAY, with Himcare, is the predominant financing mechanism for THR at this center, funding over three-quarters of procedures and most revision surgery in a young, male-predominant population, supporting an expanding role for public insurance in financing major arthroplasty in India.
SN - 2250-0685
SN - 2321-3817
ER -